XORTX Therapeutics Inc. Adjustments For Unrealised Foreign Exchange Losses Gains
XORTX Therapeutics Inc. (XRTX) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -CAD 325.74 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2022-05-03
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2021-12-31 | -325.74K CAD 20-F · filed 2022-05-03 |
| 2020-12-31 | 1.20K CAD 20-F · filed 2022-05-03 |
| 2019-12-31 | 34.06K CAD 20-F · filed 2022-05-03 |